We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Neurons Derived from the Skin Cells of Epilepsy Patients Embody New Platform for Drug Testing

By LabMedica International staff writers
Posted on 08 Aug 2013
Stem cells derived from skin taken from juvenile epilepsy patients were induced to mature into cultures of neurons that were developed into a human-based system for the study of the genetic factors that underlie the disorder and for development of drugs to control the disease.

Investigators at the University of Michigan Medical School (Ann Arbor, USA) derived forebrain-like pyramidal- and bipolar-shaped neurons from two Dravet syndrome (DS) subjects and three human controls by iPSC (induced pluripotent stem cell) reprogramming of fibroblasts. More...
DS is a severe form of childhood epilepsy typically caused by dominant mutations in the SCN1A (sodium channel, voltage-gated, type I, alpha subunit) gene encoding the voltage-gated sodium channel Nav1.1.

DS and control iPSC-derived neurons were compared using whole-cell patch clamp recordings. Sodium current density and intrinsic neuronal excitability were also examined. Results published in the July 2, 2013, online edition of the journal the Annals of Neurology revealed that neural progenitors from DS and human control iPSCs displayed a forebrain identity and differentiated into bipolar- and pyramidal-shaped neurons.

DS patient-derived neurons showed increased sodium currents in both bipolar- and pyramidal-shaped neurons. Consistent with increased sodium currents, both types of DS patient-derived neurons showed spontaneous bursting and other evidence of hyperexcitability that could potentially set off seizures. Neurons derived from the skin cells of individuals without epilepsy displayed none of this abnormal activity.

"With this technique, we can study cells that closely resemble the patient's own brain cells, without doing a brain biopsy," said senior author Dr. Jack M. Parent, professor of neurology at the University of Michigan Medical School. "It appears that the cells are overcompensating for the loss of channels due to the mutation. These patient-specific induced neurons hold great promise for modeling seizure disorders, and potentially screening medications."

The findings obtained during this study revealed a previously unrecognized cell-autonomous epilepsy mechanism underlying DS, and offer a platform for screening new antiepileptic therapies.

Related Links:

University of Michigan




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Sample Transportation System
Tempus1800 Necto
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Clinical Chemistry

view channel
Image: The steps involved in the electric field-induced capture and release (EFIRM) assay (Photo courtesy of UCLA School of Dentistry)

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation

Early detection of cancer and other serious diseases is crucial for effective treatment and improved outcomes, yet current diagnostic methods often involve invasive procedures and complex sample preparation.... Read more

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.